Lista de obras - Luisa Guidi - Dominio Público Uruguay

A Case of Hereditary Hemorrhagic Telangiectasia Associated With Crohn's Disease Successfully Treated With Infliximab

artículo científico publicado en 2010

A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery

artículo científico publicado en 2012

AID in aging and autoimmune diseases.

artículo científico publicado en 2013

Acute cytomegalovirus infection as a possible trigger for pulmonary thromboembolism in a patient with steroid-refractory ulcerative colitis.

artículo científico publicado en 2013

Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease.

artículo científico publicado en 2010

Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience

artículo científico publicado en 2011

Assay, isolation and characterization of circulating immune complexes from serum of gastrointestinal cancer, stage III and IV melanoma and chronic inflammatory bowel disease patients

artículo científico publicado en 1993

Benefit-risk assessment of golimumab in the treatment of refractory ulcerative colitis

artículo científico publicado en 2016

CT findings and clinical activity in Crohn's disease.

artículo científico publicado en 2009

Cell proliferation and ku protein expression in ageing humans

scientific article published on 01 January 1998

Changes in the amount and level of phosphorylation of p56(lck) in PBL from aging humans.

artículo científico publicado en 1998

Characteristics of gastric-vein lymphocytes with regard to the immune response to Helicobacter pylori

scientific article published on 01 August 1999

Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn's disease with anal endosonographic monitoring: a single-centre experience

scientific article published on 10 June 2008

Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients

scholarly article by Gianluca Andrisani et al published March 2013 in Journal of gastrointestinal and liver diseases : JGLD

DNA damage recognition and repair capacities in human naïve and memory T cells from peripheral blood of young and elderly subjects

scientific article published on 01 April 2003

Dermatological adverse reactions during anti-TNF treatments: focus on inflammatory bowel disease.

artículo científico

Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease

scientific article published on 03 September 2019

Effect of age on DNA binding of the ku protein in irradiated human peripheral blood mononuclear cells (PBMC)

artículo científico publicado en 1999

Enteroclysis CT and PEG-CT in patients with previous small-bowel surgical resection for Crohn's disease: CT findings and correlation with endoscopy.

artículo científico publicado en 2009

FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents

artículo científico publicado en 2013

Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year

article

Forkhead box protein 3 (FOXP3) mutations lead to increased TH17 cell numbers and regulatory T-cell instability

scientific article published on 13 October 2011

Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome.

artículo científico publicado en 2011

Ileal Crohn Disease: Mural Microvascularity Quantified with Contrast-enhanced US Correlates with Disease Activity ⬇️

artículo científico publicado el 12 de diciembre de 2011

Ileal Crohn's disease: CEUS determination of activity.

artículo científico publicado en 2012

Immune parameters in a populatio of institutionalized elderly subjects: influence of depressive disorders and endocrinological correlations ⬇️

artículo científico publicado el 1 de septiembre de 1991

Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants.

artículo científico publicado en 2012

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre

artículo científico publicado en 2020

Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study

artículo científico publicado en 2016

Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission

artículo científico publicado en 2013

Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy

artículo científico publicado en 2014

Interleukin-6 release in the hepatic blood outflow during normothermic liver ischaemia in humans

scientific article published on 01 June 2003

Latent coagulation disorders evaluated by the assay of plasma thrombin-antithrombin III complexes in a large series of 'solid tumours'

artículo científico publicado en 1992

Linking estrogen receptor β expression with inflammatory bowel disease activity

artículo científico publicado en 2015

Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis

artículo científico publicado en 2014

Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab

artículo científico publicado en 2013

Management of perianal fistulas in Crohn's disease: an up-to-date review

artículo científico publicado en 2015

Mucosal healing in ulcerative colitis: surveillance or colectomy?

artículo científico publicado en 2013

Multidetector CT enteroclysis versus barium enteroclysis with methylcellulose in patients with suspected small bowel disease.

artículo científico publicado en 2006

Myasthenia gravis, thymectomy, and antiacetycholine receptor antibody

scientific article published on 01 January 1980

Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis

artículo científico publicado en 2018

Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study.

artículo científico publicado en 2015

Patient and physician views on the quality of care for inflammatory bowel disease after one-year follow-up: Results from SOLUTION-2, a prospective IG-IBD study.

artículo científico publicado en 2017

Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.

artículo científico publicado en 2012

Prevalence of the K469E polymorphism of intercellular adhesion molecule 1 gene in Italian patients with inflammatory bowel disease.

artículo científico publicado en 2004

Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study

artículo científico publicado en 2013

Psychological status, life and social conditions: A study in a population of institutionalized elderly people

Role of immune responsiveness and DNA repair capacity genes in ageing

artículo científico publicado en 2004

Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients

artículo científico publicado en 2020

Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life Study

artículo científico publicado en 2018

TREM1 predicts response to anti-tumor necrosis factor in inflammatory bowel diseases: Towards precision medicine

scientific article published on 23 February 2019

The DNA repair protein ku is involved in gp130-mediated signal transduction events in PBMC from young but not from elderly subjects

artículo científico publicado en 2002

The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar.

artículo científico publicado en 2017

Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study

artículo científico publicado en 2018

Update on the management of inflammatory bowel disease: specific role of adalimumab.

artículo científico publicado en 2011

Use of infliximab in particular clinical settings: management based on current evidence

artículo científico publicado en 2009

Watery stools and metabolic acidosis

artículo científico publicado en 2017

What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?

artículo científico publicado en 2016

Lista de obras de Luisa Guidi

A Case of Hereditary Hemorrhagic Telangiectasia Associated With Crohn's Disease Successfully Treated With Infliximab

A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery

AID in aging and autoimmune diseases.

Acute cytomegalovirus infection as a possible trigger for pulmonary thromboembolism in a patient with steroid-refractory ulcerative colitis.

Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease.

Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience

Assay, isolation and characterization of circulating immune complexes from serum of gastrointestinal cancer, stage III and IV melanoma and chronic inflammatory bowel disease patients

Benefit-risk assessment of golimumab in the treatment of refractory ulcerative colitis

CT findings and clinical activity in Crohn's disease.

Cell proliferation and ku protein expression in ageing humans

Changes in the amount and level of phosphorylation of p56(lck) in PBL from aging humans.

Characteristics of gastric-vein lymphocytes with regard to the immune response to Helicobacter pylori

Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn's disease with anal endosonographic monitoring: a single-centre experience

Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients

DNA damage recognition and repair capacities in human naïve and memory T cells from peripheral blood of young and elderly subjects

Dermatological adverse reactions during anti-TNF treatments: focus on inflammatory bowel disease.

Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease

Effect of age on DNA binding of the ku protein in irradiated human peripheral blood mononuclear cells (PBMC)

Enteroclysis CT and PEG-CT in patients with previous small-bowel surgical resection for Crohn's disease: CT findings and correlation with endoscopy.

FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents

Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year

Forkhead box protein 3 (FOXP3) mutations lead to increased TH17 cell numbers and regulatory T-cell instability

Functional type 1 regulatory T cells develop regardless of FOXP3 mutations in patients with IPEX syndrome.

Ileal Crohn Disease: Mural Microvascularity Quantified with Contrast-enhanced US Correlates with Disease Activity ⬇️

Ileal Crohn's disease: CEUS determination of activity.

Immune parameters in a populatio of institutionalized elderly subjects: influence of depressive disorders and endocrinological correlations ⬇️

Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressants.

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre

Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study

Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission

Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy

Interleukin-6 release in the hepatic blood outflow during normothermic liver ischaemia in humans

Latent coagulation disorders evaluated by the assay of plasma thrombin-antithrombin III complexes in a large series of 'solid tumours'

Linking estrogen receptor β expression with inflammatory bowel disease activity

Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis

Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab

Management of perianal fistulas in Crohn's disease: an up-to-date review

Mucosal healing in ulcerative colitis: surveillance or colectomy?

Multidetector CT enteroclysis versus barium enteroclysis with methylcellulose in patients with suspected small bowel disease.

Myasthenia gravis, thymectomy, and antiacetycholine receptor antibody

Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis

Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study.

Patient and physician views on the quality of care for inflammatory bowel disease after one-year follow-up: Results from SOLUTION-2, a prospective IG-IBD study.

Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.

Prevalence of the K469E polymorphism of intercellular adhesion molecule 1 gene in Italian patients with inflammatory bowel disease.

Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study

Psychological status, life and social conditions: A study in a population of institutionalized elderly people

Role of immune responsiveness and DNA repair capacity genes in ageing

Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients

Sustained Clinical Efficacy and Mucosal Healing of Thiopurine Maintenance Treatment in Ulcerative Colitis: A Real-Life Study

TREM1 predicts response to anti-tumor necrosis factor in inflammatory bowel diseases: Towards precision medicine

The DNA repair protein ku is involved in gp130-mediated signal transduction events in PBMC from young but not from elderly subjects

The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar.

Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study

Update on the management of inflammatory bowel disease: specific role of adalimumab.

Use of infliximab in particular clinical settings: management based on current evidence

Watery stools and metabolic acidosis

What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?